Interleukin 3D structures
From Proteopedia
(Difference between revisions)
(3 intermediate revisions not shown.) | |||
Line 17: | Line 17: | ||
**[[3ltq]] - hIL-1 β residues 117-269 <BR /> | **[[3ltq]] - hIL-1 β residues 117-269 <BR /> | ||
**[[3pok]] - hIL-1 β residues 117-269 (mutant) <BR /> | **[[3pok]] - hIL-1 β residues 117-269 (mutant) <BR /> | ||
+ | **[[6y8i]], [[6y8m]] - hIL-1 β residues 117-269 + pyridine derivative<BR /> | ||
**[[1itb]] - hIL-1 β + IL-1 receptor 1 extracellular domain<BR /> | **[[1itb]] - hIL-1 β + IL-1 receptor 1 extracellular domain<BR /> | ||
**[[3o4o]] - hIL-1 β + IL-1 receptor 2 + IL-1 receptor accessory protein<BR /> | **[[3o4o]] - hIL-1 β + IL-1 receptor 2 + IL-1 receptor accessory protein<BR /> | ||
**[[4dep]] - hIL-1 β + IL-1 receptor 1 + IL-1 receptor accessory protein<BR /> | **[[4dep]] - hIL-1 β + IL-1 receptor 1 + IL-1 receptor accessory protein<BR /> | ||
- | **[[4g6j]], [[4g6m]], [[5bvp]] - hIL-1 β + antibody<br /> | + | **[[4g6j]], [[4g6m]], [[5bvp]], [[7chy]], [[7chz]], 7z4t]] - hIL-1 β + antibody<br /> |
**[[2kh2]] - hIL-1 β + SCFV - NMR<BR /> | **[[2kh2]] - hIL-1 β + SCFV - NMR<BR /> | ||
**[[1md6]] – mIL-1F5 – mouse<BR /> | **[[1md6]] – mIL-1F5 – mouse<BR /> | ||
Line 30: | Line 31: | ||
**[[1m47]], [[1m4c]], [[3ink]] – hIL-2<BR /> | **[[1m47]], [[1m4c]], [[3ink]] – hIL-2<BR /> | ||
- | **[[3qb1]] - hIL-2 (mutant)<br /> | + | **[[3qb1]], [[7m2g]], [[7ra9]], [[7raa]] - hIL-2 (mutant)<br /> |
**[[1irl]] – hIL-2 (mutant) - NMR<BR /> | **[[1irl]] – hIL-2 (mutant) - NMR<BR /> | ||
**[[5m5e]] - hIL-2 + IL-2 receptor β + cytokine receptor common γ<BR /> | **[[5m5e]] - hIL-2 + IL-2 receptor β + cytokine receptor common γ<BR /> | ||
Line 39: | Line 40: | ||
**[[1pw6]], [[1py2]], [[1m48]], [[1m49]] – hIL-2 + inhibitor<BR /> | **[[1pw6]], [[1py2]], [[1m48]], [[1m49]] – hIL-2 + inhibitor<BR /> | ||
**[[4nej]], [[4nem]] – hIL-2 + methylfuran carboxylate derivative<BR /> | **[[4nej]], [[4nem]] – hIL-2 + methylfuran carboxylate derivative<BR /> | ||
- | **[[5lqb]] - hIL-2 + antibody<br /> | + | **[[5lqb]], [[6ye3]], [[7dr4]] - hIL-2 + antibody<br /> |
+ | **[[7zmz]] - hIL-2 + CD25<br /> | ||
**[[4yue]] - mIL-2 + antibody<br /> | **[[4yue]] - mIL-2 + antibody<br /> | ||
**[[4yqx]] - IL-2 + antibody - rat<br /> | **[[4yqx]] - IL-2 + antibody - rat<br /> | ||
**[[4zf7]] – hIL-2 - ferret<BR /> | **[[4zf7]] – hIL-2 - ferret<BR /> | ||
+ | **[[7cjn]], [[7d9m]] – IL-2 – grass carp<BR /> | ||
*IL-3 | *IL-3 | ||
**[[1jli]] – hIL-3 (mutant) – NMR<BR /> | **[[1jli]] – hIL-3 (mutant) – NMR<BR /> | ||
+ | **[[6nmy]] – hIL-3 + IL-3 receptor α + cytokine receptor common subunit β<BR /> | ||
**[[5uv8]], [[5uwc]] – hIL-3 (mutant) + IL-3 receptor α<BR /> | **[[5uv8]], [[5uwc]] – hIL-3 (mutant) + IL-3 receptor α<BR /> | ||
**[[2l3o]] – mIL-3 residues 33-156 (mutant) - NMR | **[[2l3o]] – mIL-3 residues 33-156 (mutant) - NMR | ||
Line 72: | Line 76: | ||
*IL-6 | *IL-6 | ||
- | **[[1alu]] – hIL-6<BR /> | + | **[[1alu]], [[7nxz]] – hIL-6<BR /> |
**[[1il6]], [[2il6]] – hIL-6 - NMR<BR /> | **[[1il6]], [[2il6]] – hIL-6 - NMR<BR /> | ||
**[[1p9m]] - hIL-6 + IL-6 receptor α and β<br /> | **[[1p9m]] - hIL-6 + IL-6 receptor α and β<br /> | ||
+ | **[[8d82]] - hIL-6 + IL-6 receptor α and β – Cryo EM<br /> | ||
**[[5fuc]] - hIL-6 + IL-6 receptor α + VHH6<br /> | **[[5fuc]] - hIL-6 + IL-6 receptor α + VHH6<br /> | ||
**[[4j4l]] – hIL-6 + internalin B<BR /> | **[[4j4l]] – hIL-6 + internalin B<BR /> | ||
Line 88: | Line 93: | ||
*IL-8 | *IL-8 | ||
- | **[[ | + | **[[6n2u]] – hIL-8 <BR /> |
**[[1il8]], [[2il8]], [[5wdz]] – hIL-8 - NMR<BR /> | **[[1il8]], [[2il8]], [[5wdz]] – hIL-8 - NMR<BR /> | ||
**[[1qe6]], [[1icw]] – hIL-8 (mutant) <BR /> | **[[1qe6]], [[1icw]] – hIL-8 (mutant) <BR /> | ||
**[[1ikl]], [[1ikm]] - hIL-8 (mutant) - NMR<BR /> | **[[1ikl]], [[1ikm]] - hIL-8 (mutant) - NMR<BR /> | ||
+ | **[[3il8]], [[5d14]], [[4xdx]] – hIL-8 residues 28-99<BR /> | ||
+ | **[[6xmn]] – hIL-8 residues 28-93 + CXCR1 N-terminal - NMR<BR /> | ||
**[[1rod]] - hIL-8/melanoma growth stimulating protein – NMR<br /> | **[[1rod]] - hIL-8/melanoma growth stimulating protein – NMR<br /> | ||
- | **[[1ilp]], [[1ilq]] - hIL-8 + IL-8 receptor peptide | + | **[[1ilp]], [[1ilq]] - hIL-8 + IL-8 receptor peptide<br /> |
+ | **[[6wzm]] – hIL-8 + antibody<BR /> | ||
+ | **[[6lfm]], [[6lfo]]– hIL-8 in G-protein coupled receptor – Cryo EM<br /> | ||
+ | |||
+ | *IL-9 | ||
+ | |||
+ | **[[7ox6]] – hIL-9 - NMR<BR /> | ||
+ | **[[7ox5]] - hIL-9 + IL—9 receptor a<br /> | ||
+ | **[[7ox1]], [[7ox2]], [[7ox3]] - hIL-9 + antibody<br /> | ||
+ | **[[7xcb]] – mIL-9 <BR /> | ||
+ | **[[7ox4]] – mIL-9 + antibody<BR /> | ||
*IL-10 | *IL-10 | ||
Line 121: | Line 138: | ||
**[[5mj3]], [[5mj4]], [[5njd]] - hIL-12 β + hIL-23 α + antibody<br /> | **[[5mj3]], [[5mj4]], [[5njd]] - hIL-12 β + hIL-23 α + antibody<br /> | ||
**[[5mzv]] - hIL-12 β + hIL-23 α + hIL-23 receptor + antibody<br /> | **[[5mzv]] - hIL-12 β + hIL-23 α + hIL-23 receptor + antibody<br /> | ||
+ | **[[6wdq]] - hIL-12 β + hIL-23 α + hIL-12 receptor + hIL-23 receptor <br /> | ||
**[[5mxa]] - hIL-12 β + hIL- 23 α<br /> | **[[5mxa]] - hIL-12 β + hIL- 23 α<br /> | ||
**[[5mj3]], [[5mj4]] - hIL-12 β + hIL-23 α + alphabody MB3<br /> | **[[5mj3]], [[5mj4]] - hIL-12 β + hIL-23 α + alphabody MB3<br /> | ||
- | **[[3qwr]] - hIL-12 β + hIL- 23 α + adnectin | + | **[[3qwr]] - hIL-12 β + hIL- 23 α + adnectin<br /> |
+ | **[[6uib]] - hIL-12 β + hIL- 23 α + peptide<br /> | ||
+ | **[[6sff]], [[6smc]], [[6sp3]], [[7pur]], [[7r3n]] - mIL-12 β <br /> | ||
*IL-13 | *IL-13 | ||
Line 132: | Line 152: | ||
**[[3lb6]] - hIL-13 + IL-13 receptor α2<BR /> | **[[3lb6]] - hIL-13 + IL-13 receptor α2<BR /> | ||
**[[3bpo]], [[5e4e]] - hIL-13 residues 20-145 + IL-4 receptor α + IL-13 receptor α<br /> | **[[3bpo]], [[5e4e]] - hIL-13 residues 20-145 + IL-4 receptor α + IL-13 receptor α<br /> | ||
- | **[[5l6y]] - hIL-13 + antibody<br /> | + | **[[5l6y]], [[7rew]] - hIL-13 + antibody<br /> |
*IL-15 | *IL-15 | ||
Line 149: | Line 169: | ||
**[[4hr9]] - hIL-17A (mutant)<br /> | **[[4hr9]] - hIL-17A (mutant)<br /> | ||
**[[5n92]] - hIL-17A + hIL-17F <br /> | **[[5n92]] - hIL-17A + hIL-17F <br /> | ||
+ | **[[7uwm]] - hIL-17A + IL-17A receptor α – Cryo EM<br /> | ||
**[[4hsa]] - hIL-17A (mutant) + IL-17A receptor α <br /> | **[[4hsa]] - hIL-17A (mutant) + IL-17A receptor α <br /> | ||
**[[5nan]] - hIL-17A + hIL-17F + IL-17A receptor α <br /> | **[[5nan]] - hIL-17A + hIL-17F + IL-17A receptor α <br /> | ||
- | **[[2vxs]], [[4qhu]] - hIL-17A + antibody<BR /> | + | **[[7uwn]] - hIL-17A + IL-17A receptor α + IL-17A receptor gamma<br /> |
+ | **[[7zan]] - hIL-17A (mutant) + IL-17A receptor α + IL-17A receptor gamma<br /> | ||
+ | **[[2vxs]], [[4qhu]], [[6wio]], [[6wir]], [[7wkx]], [[7z2m]] - hIL-17A + antibody<BR /> | ||
+ | **[[8b7w]], [[8dy1]], [[8dy5]] - hIL-17A + scFv<BR /> | ||
+ | **[[8dyf]], [[8dyg]], [[8dyh]], [[8dyi]] - hIL-17A + inhibitor<BR /> | ||
**[[5vb9]] - hIL-17A + peptide inhibitor<BR /> | **[[5vb9]] - hIL-17A + peptide inhibitor<BR /> | ||
+ | **[[7ama]], [[7amg]] - hIL-17A + modulator<br /> | ||
**[[5hi5]], [[5hi4]], [[5hi3]], [[5hhx]], [[5hhv]] - hIL-17A + peptide inhibitor + antibody<BR /> | **[[5hi5]], [[5hi4]], [[5hi3]], [[5hhx]], [[5hhv]] - hIL-17A + peptide inhibitor + antibody<BR /> | ||
- | **[[1jpy]] – hIL-17F<BR /> | + | **[[1jpy]], [[6hgo]] – hIL-17F<BR /> |
- | **[[3jvf]] - hIL-17F + IL-17 receptor α | + | **[[6ppg]] – hIL-17F + antibody<BR /> |
+ | **[[3jvf]], [[6hg4]], [[6hg9]] - hIL-17F + IL-17 receptor α | ||
*IL-18 (Interferon-γ inducing factor) | *IL-18 (Interferon-γ inducing factor) | ||
Line 188: | Line 215: | ||
**[[3dlq]], [[3dgc]] - hIL-22 residues 29-179 (mutant) + IL-22 receptor α1<br /> | **[[3dlq]], [[3dgc]] - hIL-22 residues 29-179 (mutant) + IL-22 receptor α1<br /> | ||
**[[3q1s]] - hIL-22 residues 29-179 (mutant) + antibody<br /> | **[[3q1s]] - hIL-22 residues 29-179 (mutant) + antibody<br /> | ||
+ | **[[6weo]] - hIL-22 + IL-22 receptor + IL-10 receptor <br /> | ||
**[[4o6k]] – IL-22 – zebra fish<BR /> | **[[4o6k]] – IL-22 – zebra fish<BR /> | ||
Line 201: | Line 229: | ||
**[[6gg1]] - hIL-24<br /> | **[[6gg1]] - hIL-24<br /> | ||
**[[6df3]] - hIL-24 + IL—22 receptor α1 + IL-20 receptor β<br /> | **[[6df3]] - hIL-24 + IL—22 receptor α1 + IL-20 receptor β<br /> | ||
+ | |||
+ | *IL-25 | ||
+ | |||
+ | **[[7uwj]], [[7uwk]] - hIL-25 + IL—17 receptor b – Cryo EM<br /> | ||
+ | **[[7uwl]] - hIL-25 + IL—17 receptor a + IL—17 receptor b – Cryo EM<br /> | ||
+ | |||
+ | *IL-27 | ||
+ | |||
+ | **[[7u7n]], [[8d85]] - hIL-27 + IL—27 receptor a + IL-6 receptor b – Cryo EM<br /> | ||
+ | **[[7zxk]] - hIL-27 + antibody<br /> | ||
+ | **[[7zg0]] - mIL-27 + IL—27 receptor a <br /> | ||
+ | **[[7z0l]] - mIL-27 + IL—27 receptor a + IL-6 receptor b – Cryo EM<br /> | ||
*IL-28 | *IL-28 | ||
Line 214: | Line 254: | ||
**[[2kll]] - hIL-33 residues 110-270 - NMR<BR /> | **[[2kll]] - hIL-33 residues 110-270 - NMR<BR /> | ||
+ | **[[4kc3]] - hIL-33 + IL—1 receptor-like 1<br /> | ||
+ | **[[5iv4]] - mIL-33 + IL—1 receptor-like 1 + IL-1 receptor accessory protein<br /> | ||
*IL-34 | *IL-34 | ||
Line 225: | Line 267: | ||
*IL-36 | *IL-36 | ||
+ | **[[6hpi]] - hIL-36 α - NMR<br /> | ||
**[[4ize]] - hIL-36 γ<br /> | **[[4ize]] - hIL-36 γ<br /> | ||
- | **[[6p9e]] - hIL-36 | + | **[[6p9e]] - hIL-36 γ + antagonist<br /> |
*IL-37 | *IL-37 |
Current revision
3D structures of interleukin
Updated on 04-June-2023